BioCentury
ARTICLE | Company News

Institutes to conduct trials of MedImmune mAbs

October 10, 2012 1:18 AM UTC

The Cancer Research Institute and the Ludwig Institute for Cancer Research will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from MedImmune LLC combined with other immunotherapies that have yet to be chosen. Funding will be provided by the Cancer Research Institute's Cancer Vaccine Acceleration Fund. The institutes are not seeking any ownership rights. Cancer Research Institute is eligible for development milestones, which it said will be used for further investment in clinical trials. ...